Patent · US Active

Formulations for oral administration of cromolyn sodium

US8513300B2 · kind B2 · utility

19Cited by
2References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2008
Grant dateAug 20, 2013
Priority date—
Expiry dateNov 19, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/4858
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An oral dosage form comprises cromolyn sodium (sodium or disodium cromoglycate), and an acylated amino acid delivery agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.